ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $56,000 | -46.2% | 10,335 | -57.1% | 0.26% | +4216.7% |
Q1 2019 | $104,000 | -89.1% | 24,111 | -71.6% | 0.01% | -84.2% |
Q1 2018 | $953,000 | +197.8% | 84,925 | +116.9% | 0.04% | +137.5% |
Q3 2017 | $320,000 | +196.3% | 39,158 | +62.4% | 0.02% | +166.7% |
Q2 2017 | $108,000 | -41.9% | 24,108 | -28.6% | 0.01% | -33.3% |
Q1 2017 | $186,000 | +6.3% | 33,773 | +56.4% | 0.01% | +12.5% |
Q1 2016 | $175,000 | -34.0% | 21,600 | -1.8% | 0.01% | -38.5% |
Q4 2015 | $265,000 | – | 22,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 15,832,611 | $68,080,000 | 3.54% |
Matrix Capital Management Company, LP | 28,000,000 | $120,400,000 | 3.21% |
Virtus ETF Advisers LLC | 50,655 | $218,000 | 0.46% |
TFG Asset Management GP Ltd | 500,000 | $2,150,000 | 0.27% |
Rock Springs Capital Management LP | 800,000 | $3,440,000 | 0.13% |
Orbimed Advisors | 1,350,655 | $5,808,000 | 0.09% |
Vident Investment Advisory, LLC | 289,340 | $1,244,000 | 0.07% |
WS MANAGEMENT LLLP | 185,537 | $798,000 | 0.05% |
Rathbones Group PLC | 285,722 | $1,229,000 | 0.04% |
Tekla Capital Management LLC | 228,496 | $983,000 | 0.04% |